カタログ製品コード : C-EK1942

Human C-Reactive Protein ELISA kit

*写真はイメージです
24T ¥47,000 (¥1,958/T) (税別)
48T ¥61,000 (¥1,271/T) (税別)
96T ¥69,800 (¥727/T) (税別)
標準納期 : 1週間
メーカー名 遺伝子名 種交差性 測定範囲 サンプル量 適用サンプル ドキュメント
MultiSciences C-Reactive Protein/CRP Human 62.50 - 4000 pg/ml 50 μl (prediluted) 血清、血漿、細胞培養上清

保存方法 :

キットは未開封の場合、4℃で保管すること。 開封後は標準溶液を-20℃で保存し、他の試薬は4℃で保存すること。

構成内容 :

96-well polystyrene microplate coated with a monoclonal antibody against C-Reactive Protein
Human C-Reactive Protein Standard, lyophilized
C-Reactive Protein Detect Antibody
Streptavidin-HRP
Assay Buffer (10×)
Substrate (TMB)
Stop Solution
washing Buffer (20×)
Plate Covers

キーワード :

Homo sapiens,Human,C-reactive protein,CRP,PTX1

ターゲット情報 :

This assay employs the quantitative sandwich enzyme immunoassay technique for the quantitative detection of human CRP. The Human CRP ELISA is for research use only. Not for diagnostic or therapeutic procedures.
C-reactive protein (CRP) is an annular, pentameric protein. The physiological role of CRP is to bind to lysophosphatidylcholine expressed on the surface of dead or dying cells (and some types of bacteria) in order to activate the complement system via the C1Q complex. CRP is an acute phase protein in humans and is an important mediator of immune host defense. The acute phase response occurs in response to a wide range of acute and chronic inflammatory conditions such as bacterial, viral, or fungal infections; rheumatic and other inflammatory diseases; malignancy; and tissue injury and necrosis. These conditions cause release of IL-6 and other cytokines that trigger the synthesis of CRP and fibrinogen by the liver. CRP plays a role in innate immunity as an early defense system against infections. Monitoring of CRP levels in serum provides more detailed insights in several pathological situations such as inflammatory disease (including inflammatory bowel disease, Intestinal Lymphoma, Intestinal Tuberculosis and Behcet's Syndrome), cancer, diabetes, hypertension, cardiovascular disease, obstructive sleep apnea and so on.